Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Clark

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Trauma Case Reports|December 28, 2020
Home versus indoor trampoline park injuries: A four-year review of hospital admissions, associated costs, and impact on patientsSylvia J Gautreau, Lia R Massoeurs, William W Allanach, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2022
Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimensDaniel N Maxwell, Jiwoong Kim, Christine A Pybus, et al.
International Journal of Antimicrobial Agents|January 23, 2023
Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United StatesTomefa E Asempa, April M Bobenchik, Lori Bourassa, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2025
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of <i>Enterobacterales</i> from outpatient centers and nursing homes across the United States (2022-2024)Aliaa Fouad, April M Bobenchik, Robin Chamberland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2026
A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-DurlobactamSima L Sharara, Lorena Diaz, Tomefa E Asempa, et al.
Journal of Clinical Microbiology|April 8, 2021
Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated GroupsMadhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, et al.
Clinical Chemistry|May 26, 2022
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of ConcernAndrew E Clark, Zhaohui Wang, Emily Ostman, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2025
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio studyEcem Buyukyanbolu, Jill Argotsinger, Eric T Beck, et al.
Microbiology Spectrum|March 23, 2026
Antimicrobial activity of sulbactam-durlobactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025)Elizabeth Cyr, Jill Argotsinger, Eric T Beck, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Trauma Case Reports|December 28, 2020
Home versus indoor trampoline park injuries: A four-year review of hospital admissions, associated costs, and impact on patientsSylvia J Gautreau, Lia R Massoeurs, William W Allanach, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2022
Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimensDaniel N Maxwell, Jiwoong Kim, Christine A Pybus, et al.
International Journal of Antimicrobial Agents|January 23, 2023
Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United StatesTomefa E Asempa, April M Bobenchik, Lori Bourassa, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2025
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of <i>Enterobacterales</i> from outpatient centers and nursing homes across the United States (2022-2024)Aliaa Fouad, April M Bobenchik, Robin Chamberland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2026
A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-DurlobactamSima L Sharara, Lorena Diaz, Tomefa E Asempa, et al.
Journal of Clinical Microbiology|April 8, 2021
Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated GroupsMadhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, et al.
Clinical Chemistry|May 26, 2022
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of ConcernAndrew E Clark, Zhaohui Wang, Emily Ostman, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2025
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio studyEcem Buyukyanbolu, Jill Argotsinger, Eric T Beck, et al.
Microbiology Spectrum|March 23, 2026
Antimicrobial activity of sulbactam-durlobactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025)Elizabeth Cyr, Jill Argotsinger, Eric T Beck, et al.
Pageof 7